MG-D-2020

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMG-D-2020
Drug Alias NameMG-D-2020
ClassificationOther
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMetagone Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesMetagone Biotech Inc
Inactive CompaniesN/A
Active IndicationsNeoplasm Metastasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A